lisinopril + losartan + atorvastatin

**lisinopril + losartan + atorvastatin** is a non-standard, hypothetical combination of three medications: lisinopril, losartan, and atorvastatin. - **Lisinopril** is an angiotensin-converting enzyme (ACE) inhibitor used primarily to treat high blood pressure, heart failure, and to improve survival after heart attacks. It works by reducing the production of angiotensin II, leading to vasodilation and reduced blood pressure[1][2]. - **Losartan** is an angiotensin II receptor blocker (ARB) indicated for hypertension, reduction of stroke risk in people with left ventricular hypertrophy, and kidney protection in type 2 diabetes. It blocks angiotensin II receptors, preventing vasoconstriction and lowering blood pressure[1][3]. - **Atorvastatin** is a statin used to lower cholesterol and triglyceride levels, and to reduce cardiovascular risk. It works by inhibiting HMG-CoA reductase, the key enzyme in cholesterol synthesis[6]. This precise triple combination is not known to be marketed as a fixed-dose product, and there are safety concerns about combining both an ACE inhibitor and an ARB due to overlapping mechanisms and risk of adverse effects such as hyperkalemia, hypotension, and renal dysfunction[4]. Fixed-dose combinations more commonly pair an ACE inhibitor or an ARB with a diuretic or a statin, but not both together[5][7].